… on the mechanisms of drug resistance in bladder cancer. … the development of drug resistance
in patients with bladder cancer will … resistance in patients with advanced urothelial cancer. …

… of bladder cancer; however, its response rate is not satisfactory due to the development of
drug resistance. The potential for phytochemicals to reverse drug resistance in bladder cancer …

… may be a potential candidate for reversing drug resistance in bladder cancer chemotherapy.
… treatment of bladder cancer and drug resistance. The cell ADM resistance reversal assay …

… The aim of the study is to investigate the ability of phytochemicals to overcome the
multiple drug resistance (MDR) of bladder cancer. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium …

Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …

… In the present study we investigated the expression of ANXA1 in bladder cancer drug-resistant
cell lines and bladder cancer tissues of different interval of relapse. The results …

… resistant to doxorubicin than MGH-Ul. In the present study, MGH-UlR was evaluated for its
multi-drug resistance … be 188 times more resistant to vinblastine and 13 times more resistant to …

… study between the drug resistance to doxorubicin in bladder cancer and the gene … expressions
participate in resistance to doxorubicin in bladder cancer patients. In bladder cancer, the …

… of drug-resistant traits. Within this review, we illuminate contemporary insights into the role
of clonal evolution in bladder cancer, … , and the formidable obstacle of therapy resistance. …

… of annexin A2 in bladder cancer cell lines and bladder cancer tissues, we want to find the
relationship among annexin A2, drug resistance, and recurrence of bladder cancer. …